Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
May 11, 2023
Tickers
OPTHF
From Benzinga
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
May 11, 2023
From Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
May 10, 2023
Tickers
HUGE
From Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
From Benzinga
From Benzinga
From Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
From Benzinga
Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings
May 07, 2023
Tickers
COPHF
From Benzinga
From Benzinga
NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
May 05, 2023
From Benzinga
Washington State County Decriminalizes Psychedelics, Gov. Calls For Special Session On Drug Policy
May 04, 2023
From Benzinga
International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance
May 03, 2023
From Benzinga
Colorado's Rapidly-Progressing Measure For Legal Psychedelics Regulation Heads To Gov.'s Desk
May 03, 2023
From Benzinga
Psychedelics Reform Update: Arizona's MDMA Gets Gov's Signature, California, Minnesota & Missouri's Progress
May 02, 2023
From Benzinga
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
May 02, 2023
From Benzinga
EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects
April 27, 2023
From Benzinga
Colorado Takes Another Step In Psychedelics Regulation As Amended Bill Receives Approval
April 26, 2023
From Benzinga
Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued
April 26, 2023
From Benzinga
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
April 26, 2023
Tickers
MSSTF
From Benzinga
From Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
From Benzinga
Psychedelics Reform Update: NC's $5M Grant, WA's Pilot Program, Plus Rescheduling Proposals
April 21, 2023
From Benzinga
Psychedelics Therapy For Teens, Elders, And Borderline Disorder Patients: Here Are The Latest Findings
April 21, 2023
From Benzinga
Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off
April 20, 2023
Tickers
CMND
From Benzinga
Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up
April 20, 2023
Tickers
LOBEF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.